Carbon monoxide decreases interleukin-1β levels in the lung through the induction of pyrin

Cellular and Molecular Immunology

Volumn 14, Issue 4, 2017, Pages 349-359

  Kim, Seul Ki ^a   Joe, Yeonsoo ^a   Chen, Yingqing ^a   Ryu, Jinhyun ^b   Lee, Jeong Hee ^b   Cho, Gyeong Jae ^b   Ryter, Stefan W ^c   Chung, Hun Taeg ^a  

^a University of Ulsan   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Anti inflammatory effects; carbon monoxide (CO); IL 1 ; inflammasome; pyrin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON MONOXIDE; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; PYRIN; SMALL INTERFERING RNA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA INTERFERENCE; SPLEEN; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENETICS; LUNG; METABOLISM;

ANIMALS; CARBON MONOXIDE; CELL LINE; DOWN-REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LUNG; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PYRIN; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 85016810149     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.79     Document Type: Article

References (47)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
2. Grailer JJ, Canning BA, Kalbitz M, Haggadone MD, Dhond RM, Andjelkovic AV, et al. Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol 2014; 192: 5974-5983.
3. Guo H, Callaway JB, Ting JP. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat Med 2015; 21: 677-687.
4. Franchi L, Munoz-Planillo R, Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012; 13: 325-332.
5. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674-677.
6. Martinon F, Burns K, Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
7. Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004; 14: 1929-1934.
8. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
9. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006; 440: 233-236.
10. Arlehamn CS, Petrilli V, Gross O, Tschopp J, Evans TJ. The role of potassium in inflammasome activation by bacteria. J Biol Chem 2010; 285: 10508-10518.
11. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157: 1013-1022.
12. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14: 1457-1466.
13. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807.
14. French FMFC. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
15. Mariathasan S. ASC, Ipaf and Cryopyrin/Nalp3: Bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect 2007; 9: 664-671.
16. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-3231.
17. Xu P, Wen Z, Shi X, Li Y, Fan L, Xiang M, et al. Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction. J Immunol 2013; 190: 5247-5255.
18. Grandemange S, Aksentijevich I, Jeru I, Gul A, Touitou I. The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun 2011; 12: 497-503.
19. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 2007; 282: 1718-1726.
20. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-428.
21. Mishra S, Fujita T, Lama VN, Nam D, Liao H, Okada M, et al. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci USA 2006; 103: 5191-5196.
22. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, et al. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003; 163: 231-242.
23. Pulido JN, Neal JR, Mantilla CB, Agarwal S, Lee WY, Scott PD, et al. Inhaled carbon monoxide attenuates myocardial inflammatory cytokine expression in a rat model of cardiopulmonary bypass. J Extra Corpor Technol 2011; 43: 137-143.
24. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess JR, Scalea TM. Trauma mortality in mature trauma systems: Are we doing better? An analysis of trauma mortality patterns, 1997-2008. J Trauma 2010; 69: 620-626.
25. Kohmoto J, Nakao A, Sugimoto R, Wang Y, Zhan J, Ueda H, et al. Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2008; 136: 1067-1075.
26. Dolinay T, Choi AM, Ryter SW. Heme oxygenase-1/CO as protective mediators in cigarette smoke-induced lung cell injury and chronic obstructive pulmonary disease. Curr Pharm Biotechnol 2012; 13: 769-776.
27. Chhikara M, Wang S, Kern SJ, Ferreyra GA, Barb JJ, Munson PJ, et al. Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-kappaB signal transduction in human monocytes. PLoS One 2009; 4: E8139.
28. Katada K, Bihari A, Mizuguchi S, Yoshida N, Yoshikawa T, Fraser DD, et al. Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 2010; 33: 92-100.
29. Uddin MJ, Jeong SO, Zheng M, Chen Y, Cho GJ, Chung HT, et al. Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3beta signaling. Oxid Med Cell Longev 2013; 2013: 210563.
30. Kim HJ, Joe Y, Kong JS, Jeong SO, Cho GJ, Ryter SW, et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev 2013; 2013: 306421.
31. Kim SK, Joe Y, Zheng M, Kim HJ, Yu JK, Cho GJ, et al. Resveratrol induces hepatic mitochondrial biogenesis through the sequential activation of nitric oxide and carbon monoxide production. Antioxid Redox Signal 2014; 20: 2589-2605.
32. Fang WF, Cho JH, He Q, Lin MC, Wu CC, Voelkel NF, et al. Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2007; 293: L336-L344.
33. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30. 2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006; 103: 9982-9987.
34. Tidow N, Chen X, Muller C, Kawano S, Gombart AF, Fischel-Ghodsian Net al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 2000; 95: 1451-1455.
35. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-190.
36. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001; 166: 4185-4194.
37. Nakao A, Moore BA, Murase N, Liu F, Zuckerbraun BS, Bach FH, et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52: 1278-1285.
38. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7: 598-604.
39. Zhou H, Liu J, Pan P, Jin D, Ding W, Li W. Carbon monoxide inhalation decreased lung injury via anti-inflammatory and anti-apoptotic effects in brain death rats. Exp Biol Med 2010; 235: 1236-1243.
40. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, et al. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 2006; 203: 2377-2389.
41. Bilban M, Bach FH, Otterbein SL, Ifedigbo E, d'Avila JC, EsterbauerH, et al. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 2006; 24: 601-610.
42. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 2009; 182: 3809-3818.
43. Jamal Uddin M, Joe Y, Kim SK, Oh Jeong S, Ryter SW, Pae HO, et al. IRG1 induced by heme oxygenase-1/carbon monoxide inhibits LPSmediated sepsis and pro-inflammatory cytokine production. Cell Mol Immunol 2015. doi: 10. 1038/cmi. 2015. 02. [Epub ahead of print].
44. Gavrilin MA, Mitra S, Seshadri S, Nateri J, Berhe F, Hall MW, et al. Pyrin critical to macrophage IL-1beta response to Francisella challenge. J Immunol 2009; 182: 7982-7989.
45. Gavrilin MA, Abdelaziz DH, Mostafa M, Abdulrahman BA, Grandhi J, Akhter A, et al. Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia. J Immunol 2012; 188: 3469-3477.
46. Joe Y, Uddin MJ, Zheng M, KimHJ, Chen Y, YoonNA, et al. Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSSinduced colitis. PLoS One 2014; 9: E88776.
47. Sheikh SZ, Hegazi RA, Kobayashi T, Onyiah JC, Russo SM, Matsuoka K, et al. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol 2011; 186: 5506-5513.